Max Rosett's Insider Trades & SAST Disclosures
Max Rosett's most recent trade in Immunome Inc was a trade of 42,000 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on Sept. 19, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Max Rosett.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Max Rosett | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 19 Sep 2024 | 42,000 | 61,856 | - | 1.1 | 44,100 | Common Stock |
| Immunome Inc | Max Rosett | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Sep 2024 | 42,000 | 91,848 | - | - | Stock option (right to buy) | |
| Immunome Inc | Max Rosett | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.01 per share. | 19 Sep 2024 | 14,380 | 47,476 | - | 16.0 | 230,224 | Common Stock |
| Immunome Inc | Max Rosett | EVP, Operations & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 190,000 | 190,000 | - | - | Stock option (right to buy) | |
| Immunome Inc | Max Rosett | EVP, Operations & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 30,000 | 30,000 | - | - | Stock option (right to buy) | |
| Immunome Inc | Rosett Max | EVP, OPERATIONS & INTERIM CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 175,000 | 175,000 | - | - | Stock option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges